Interferon alpha (IFNa) has been used in the treatment of several types of cancer for almost 30 years, yet the mechanism(s) responsible for its anti-tumoral action remains unknown. A variety of cellular responses, including inhibition of cell growth and induction of apoptosis are induced by IFNs, and apoptotic induction by this cytokine has been proposed to be of importance for both its anti-tumoral in addition to its anti-viral responses. The aim of the present study was to delineate the pathways activated during IFNa-induced apoptosis in malignant cell lines. We found that apoptosis induced by IFNa was associated with activation of caspases-1, -2, -3, -8 and -9 and that this activation was a critical event. Caspase-3 activation was dependent on activity of caspases-8 and -9, moreover, activation of caspase-8 seems to be the upstream event in IFNa-induced caspase cascade. We also found loss of mitochondrial membrane potential as well as release of cytochrome c post IFNtreatment, clearly implicating the involvement of mitochondria in IFN-mediated apoptosis. Furthermore, IFNa-induced apoptosis was found to be independent on interactions between the Fas-receptor and its ligand. These studies form the basis for further investigations aiming to improve IFN therapy and the development of future strategies to overcome the IFN resistance observed in some malignancies.
Introduction
Apoptosis is a genetically regulated cellular suicide process that plays an important role in the control of many normal physiological events, such as embryonic development, immune regulation and maintenance of tissue homeostasis (Krammer, 2000; Meier et al., 2000) .
Decreased sensitivity to apoptotic stimuli is a trait commonly shared by cancer cells which provides them with a survival advantage facilitating the outgrowth of malignant clones (Niesvizky et al., 1993; Raza, 2000) . Because of this, cancer cells are also variably susceptible to apoptosis induced by cytotoxic drugs such as 5-¯uorouracil (5-FU), doxorubicin and cisplatin (Witzig et al., 2000) . Thus, alterations that decrease the ability to activate the apoptotic machinery might play a role in resistance to many anticancer drugs (Los et al., 1997) .
Interferon alpha (IFNa) has been used clinically in the treatment of a variety of cancers for over 30 years but the molecular mechanism behind its cytoreductive action is still unknown. The anti-proliferative eect of IFNa has been suggested to play a major role in its chemotherapeutic eect. However, recent research has also indicated its action in the apoptosis pathways as a possible anti-tumour mechanism (Luchetti et al., 1998) . Several studies have shown that IFN can exert direct cytotoxic eects on primary malignant cells and tumour cell lines in vivo (Grander et al., 1993; Manabe et al., 1993; Sangfelt et al., 1997) and IFN has also been demonstrated to be a direct inducer of apoptosis (Sangfelt et al., 1997; Dai and Krantz, 1999) . Induction of apoptosis is thus a highly attractive mechanism of action for IFN's anti-tumoral response and it could also play a role in the clearing of virus infected cells. The molecular background to IFNa-induced apoptosis remains unclear, but some studies indicate that the eect occurs independently of cell cycle arrest and presence of wild type p53, nor does it correlate with the expression pattern of Bcl-2 or Bax proteins (Sangfelt et al., 1997) . Furthermore, in myeloma, as well as in glioma cell lines, long term treatment with IFN has been suggested to sensitize the cells to Fas-induced apoptosis, by an as yet unknown mechanism (Spets et al., 1998; Roth et al., 1998) Two major cell-intrinsic pathways have been described for induction of apoptosis, one beginning at the level of cell surface death receptors, the other involving activation of mitochondria followed by release of cytochrome c. The induction of these pathways triggers the activation of caspase cascades (Belka et al., 2000; Hengartner, 2000) . To date, 14 dierent caspases have been described (Earnshaw et al., 1999; Thornberry and Lazebnik, 1998) . Although overexpression of each of these can kill cells by apoptosis, not all of them are normally involved in this process. Caspases-8 and -9 are the major initiator caspases. Caspase-8 activation is triggered by binding of death ligands to their cognate receptors, whereas caspase-9 is activated as a result of mitochondrial cytochrome c release and the subsequent formation of an apoptosome complex. Caspases-3, -6 and -7 are the major eector caspases and when activated they cleave the vast majority of proteins that undergo proteolysis in apoptotic cells (Earnshaw et al., 1999; Green, 1998; Kumar, 1999; Slee et al., 1999) . The role in apoptosis and the events leading to activation of caspase-2 are far from clear, although this caspase has been shown to be activated as a result of TNF-receptor signalling (Kumar, 1999) . Involvement of caspase-1 in apoptosis has been frequently debated, as it may primarily be involved in the processing of proin¯ammatory cytokines (Miura et al., 1993) . Furthermore, caspases also play a role in other non-apoptotic related events such as dierentiation (Zeuner et al., 1999) .
Based on our previous ®nding that IFNa induces a strong apoptotic response in some malignant cell lines, we decided to investigate the mechanistic events leading to this eect. Our aim was to delineate the molecular pathways involved in IFNa-induced apoptosis, and to elucidate whether or not this process is mediated by caspase activation, and if so, which caspases are of importance. Our results show that IFNa induces activation of several caspases, both the initiator caspases-8 and -9 and the eector caspase-3, in addition to caspases-1 and -2. Inhibition of the caspases resulted in signi®cantly reduced apoptosis. We could also show that induction of apoptosis correlated with a loss of mitochondrial membrane potential and a release of cytochrome c into the cytoplasm. Furthermore, IFNainduced apoptosis was not inhibited by antagonistic antibodies to the Fas-receptor.
Results

IFNa induces apoptosis and/or cell cycle arrest in malignant cells
Treatment of the three cell lines used in this study with IFNa for up to 48 h leads to prominent although dierent eects regarding the induction of apoptosis and cell cycle changes. As previously shown (Sangfelt et al., 1997) , IFNa induces both apoptosis and G 1 -phase arrest in U266 cells, whereas Daudi cells are exclusively cell cycle arrested in the G 1 /G 0 -phase. The Rhek-1 cell line responds to IFNa-treatment by induction of apoptosis without any prominent G 1 -arrest being observed (Figure 1 ).
Induction of apoptosis by IFNa correlates with the activation of caspases
In order to gain a better understanding of the apoptotic pathways activated by IFNa in malignant cells, and to delineate the mediators responsible for this process, we cultured the cells in the presence or absence of IFN and subsequently investigated the activation of caspases-1, -2, -3, -8 and -9.
Measurement of caspase activation at timepoints ranging between 2 and 48 h showed that in U266 cells, caspases-1, -2, -3, -8 and -9 are activated after 16 ± 24 h of IFN exposure (Figure 2b ). IFN-induced activation of caspases-1, -8 and -9 is observed almost simultaneously after 24 h of culturing and their activity continues to increase thereafter. Activation of caspases-2 and -3 is found at 20 h and these caspases also show a greater relative activation, as compared to the other caspases analysed. In great similarity, Rhek-1 cells also exhibit activation of caspases-2, -3, -8 and -9 after 8 ± 24 h of culture in the presence of IFN ( Figure  2a ). In the Daudi cell line, where no apoptosis was detected, we did not observe activation of any of these caspases ( Figure 2c ). The reason for the slight decrease in activity of all caspases at later timepoints in this cell line is probably due to cell growth inhibition. It was also noted that in all the caspases studied, the basal activity in U266 and Rhek-1 cells exceeded the basal activity in Daudi cells with an approximately 10-fold dierence (data not shown).
To ascertain the activation of two caspases that have been shown to be of great importance in many apoptotic systems, caspase-3 and -8, Western blot analysis for these caspases was performed on protein extracts from U266 and Rhek-1 cells. Cleavage of both caspases was clearly observed after 24 and 48 h of IFN-treatment. It was also noted that the levels of procaspase-3 were slightly increased in IFN-treated samples at the two latest timepoints, whereas the levels of pro-caspase-8 remained stabile throughout the experiment (Figure 3 and data not shown)
Effects of caspase inhibitors on IFNa-induced apoptosis
With the aim to investigate the order and relative importance of the dierent caspases found to be activated during IFNa-induced apoptosis, the cells were treated with various caspase inhibitors and the eects on apoptosis and activation of other caspases were evaluated. For these blocking experiments, the optimal concentration of each inhibitor was carefully titrated in order to avoid unspeci®c inhibition of other caspases (data not shown).
In order to determine the overall importance of caspase activation in IFNa-induced apoptosis we initially performed blocking experiments using the pan-caspase inhibitor ZVAD-fmk. U266 cells were pre-treated with 50 mM of this inhibitor for 1 h prior to IFNa addition and cultured for an additional 24 and 48 h in the presence or absence of IFNa. The results showed a reduction in IFNa-induced apoptosis by around 80% at 24 h (Table 1) (Table 1) .
Furthermore, activation of caspase-3 in cells treated with ZVAD-fmk was completely blocked after 24 and 48 h of culture ( Figure 5 ). We also observed that inhibition of caspase activity with ZVAD-fmk had no eect on the cell cycle changes induced by IFNa (data not shown).
Activation of caspase-3 is regarded as a common executional step in all apoptotic pathways. Since the presence of ZVAD-fmk reduced the amount of apoptosis in our system, as well as blocked activation of caspase-3, we wanted to evaluate whether inhibition of this caspase with 5 mM DEVD-fmk had a similar eect on IFNa-induced apoptosis. Annexin V analysis revealed that this inhibitor caused an approximate 50% reduction in IFNa-induced apoptosis after 24 and 48 h (Table 1) . Caspase activity assay showed that treatment with DEVD resulted in inhibition of caspase-3 ( Figure  6a ), whereas activation of caspases-2, -8 and -9 was essentially unaected. This suggests that caspases other than caspase-3 are initiating the IFNa-induced caspase cascade.
Aiming to investigate what upstream caspases that might be of importance in IFNa-induced apoptosis the cells were treated with 1 mM VDVAD-fmk, 10 mM IETD-fmk and 1 mM LEHD-fmk, inhibitors of caspases-2, -8 and -9 respectively. The amount of apoptosis and activation of caspases-2, -3, -8 and -9 was subsequently analysed, with results showing that inhibition of caspase-2 using VDVAD-fmk has a rather weak eect on apoptosis (Table 1) , but clearly reduces the activation of both caspase-9 and caspase-3 ( Figure 6b ). The results using VDVAD-fmk should, however, be interpreted with some caution since this inhibitor is also a partial, but less eective (100 ± 1000 times), inhibitor of caspases-3 and -9 (Thornberry et al., 1997) . The reason for the rather poor protection against apoptosis with VDVAD-fmk as compared to DEVD-fmk, could be explained by both the incomplete inhibition of caspase-3 by VDVAD-fmk ( Figure 6a ,b) as well as the fact that DEVD-fmk also can cause inhibition of caspase-7 (Thornberry et al., 1997) . Caspase-9 inhibition lead to reduced caspase-3 activation whereas no eect could be observed on caspase-2 activity ( Figure 6c ). Furthermore, inhibition of this caspase resulted in a weak reducing eect on IFNa-induced apoptosis (Table 1) . Caspase-8 inhibition, on the other hand, resulted in a strong reduction in IFNa-induced apoptosis at 24 and 48 h (Table 1) , and furthermore, reduced the activation of caspases-2, -3 and -9 (Figure 6d ,e). Inhibition of caspase-1 with 50 mM YVAD-cmk was also performed. The results demonstrate that caspase-1 inhibition has no eect on IFNa-induced apoptosis (Table 1) indicating that caspase-1 is not crucial in this process.
Taken together, the above mentioned results indicate that IFNa-induced apoptosis is dependent on activation of caspases-2, -3, -8 and -9 but independent on caspase-1 activation. Furthermore, IFNa-induced caspase-8 activation seems to be independent on activation of all other caspases investigated and therefore probably lies upstream in the caspase cascade, acting to mediate caspase-2, -3 and -9 activation. The fact that inhibition of this caspase also shows the largest inhibition of IFN-induced apoptosis as compared to the other speci®c caspase inhibitors further strengthens this notion (Table 1) . Activation of caspase-3 on the other hand is clearly a downstream event, mediated by caspases-8 and -9.
The involvement of mitochondria in IFNa-induced apoptosis
It has been found that alterations of mitochondrial functions might play a major role in apoptosis induced by a number of chemotherapeutic agents (Kataoka et al., 1998; Sun et al., 1999) . Dierent models have been proposed to explain the relationship between activation of caspases and loss of mitochondrial membrane integrity. A common event is the release of cytochrome c and apoptosis inducing factor (AIF) from the intermembrane space although the ordering of events triggering and following permeability transition are unclear at present. In order to investigate the Hybridization with Cdk4 and tubulin antibodies was used as control for equal loading. We have previously shown that Cdk4 levels do not change during IFN treatment involvement of mitochondria in IFNa-induced apoptosis, cells were cultured in the absence or presence of IFNa for timepoints ranging between 12 and 48 h and thereafter incubated with TMRE, for de®nition of cells with a functional electron transport, and Annexin V simultaneously. In the two apoptosis sensitive cell lines, Rhek-1 and U266, a population of the IFN-treated cells exhibit a clear loss of C mit . This is ®rst observed after 12 ± 16 h for Rhek-1 cells (data not shown) and 20 ± 24 h for U266 cells (Figure 7a ) post IFNatreatment. However, in both cell lines the largest reduction in C mit was at 48 h. It was also shown by gating of apoptotic cells as measured by Annexin V positivity that loss of C mit and apoptosis occurred in the same cell population (data not shown). In the Daudi cell line, insensitive to apoptosis induced by IFNa, we could not observe any loss of C mit ( Figure  7b ). We also noted that in the population of cells where no loss of C mit could be observed, there was a slight shift towards an increased cellular TMRE positivity at around 48 h in the IFNa-treated samples in both Daudi and U266 cells (Figure 7) . The reason for this is unclear, but a similar phenomenon has been observed in other systems (Stridh et al., 1999) .
In order to analyse whether the previously observed caspase-9 activation may be associated with cytochrome c release from mitochondria we performed combined immunostaining experiments using mitotracker, a dye that accumulates in mitochondria, and an antibody against cytochrome c. When comparing U266 cells cultured in absence and presence of IFN for 24 and 48 h, we found that in cells exposed to IFN and showing fragmented nuclei, cytochrome c could no longer be found speci®cally in mitochondria, indicative of cytochrome c release (Figure 8 ).
In conclusion, the results from analysing mitochondrial membrane potential, cytochrome c release and caspase-9 activation, all strongly support the notion that IFNa-mediated apoptosis involves the mitochondrial pathway.
IFNa-induced apoptosis is not dependent on Fas signalling
It has been reported that treatment with IFNa or IFNg can upregulate expression of both the Fas receptor and the Fas-ligand (Kaser et al., 1999; Dai et al., 1998; Bernassola et al., 1999; Spets et al., 1998) and that inhibition of Fas-signalling during IFNg-treatment partially inhibits apoptosis (Bernassola et al., 1999; Dai et al., 1998) . Engagement of the Fas-ligand to its receptor results in formation of the death inducing signalling complex, the DISC, with caspase-8 acting as one of the components. In order to investigate a possible involvement of the Fas-signalling system in IFNa-induced apoptosis, we studied the eect of a neutralising antibody to the Fas-receptor in our system. Treatment with this Fas-receptor antagonistic antibody had no reducing eect on IFNa-induced apoptosis (data not shown), indicating that this process is independent of functional FasR ± FasL interactions.
Discussion
We and others have previously shown that IFNa can induce a cytotoxic eect in primary tumour cells and also acts as a potent inducer of apoptosis in some malignant cell lines. (Grander et al., 1993; Manabe et al., 1993; Sangfelt et al., 1997; Dai and Krantz, 1999) . This latter eect has been proposed to be of major (Tamura et al., 1995) , but only in some cases it has been possible to ®t these genes into the more general scheme of known apoptosis regulating genes (Gil and Esteban, 2000) . Interestingly, the STAT1 molecule, which is directly activated through phosphorylation following binding of IFN to its receptor, has been demonstrated to be involved in apoptosis regulation in several ways. Recently, STAT1 was found to modulate TNFa-induced apoptosis through interaction with the TNF-R/TRADD complex . STAT1 has also been shown to be crucial in maintaining basal levels of caspases in cells (Kumar et al., 1997) . This latter function however, is not related to the formation of the transcription factor ISGF3 or STAT1 homodimer complexes, that are thought to mediate IFN-induced transcription, as it is possible to mutate the tyrosine site required for IFNinduced transcriptional activation without changing caspase levels. Consistent with this, in the present study we did not observe any major changes in caspase levels following IFN-treatment as measured by Western blotting.
In order to obtain a greater understanding of the molecular events underlying IFNa-induced apoptosis, and to de®ne how these may relate to known apoptotic pathways, we have in the present investigation carefully studied the temporal activation of a set of caspases. Furthermore, the hierarchy in the IFNa-induced caspase cascade was investigated through the use of speci®c caspase inhibitors. The dierent proteases in the caspase family have several important roles in the molecular control of apoptosis, as triggers of the apoptotic process, as regulatory elements within it and as executioners of cell destruction. Furthermore, establishing the repertoire and ordering of caspase activation may give important information on the pathway(s) used in the activation of the cell death program by an individual pro-apoptotic signal.
Our data clearly demonstrate that caspases-1, -2, -3, -8 and -9 are activated at dierent timepoints following IFN-treatment in two transformed cell lines of various origins. This caspase activation seems to be of major importance for the execution of IFN-induced apoptosis in these cells, since treatment of cells with the pancaspase inhibitor ZVAD-fmk, resulted in a strong reduction in the amount of apoptotic cells, whereas IFN-induced cell cycle arrest could still be observed. A small fraction of cells still undergo apoptosis despite an ecient blockage of caspase activity in ZVAD-fmk treated cells. This could theoretically be due to that parts of the IFNa-induced apoptotic features are to some extent brought about by caspase independent mechanisms (Chi et al., 1999) such as release of AIF from the mitochondria , or activation of proteases not inhibited by ZVAD-fmk (Armstrong et al., 1996) . Another reason could be instability of the inhibitor in the cell culture, although this seems less likely since the activity of caspase-3 remains inhibited also at late timepoints.
By using peptide inhibitors of speci®c caspases we could furthermore demonstrate that activation of caspases-2, -3, -8 and -9 all seem to have a role in IFN-induced cytotoxicity, since reduction in the amount of apoptotic cells in IFN treated cultures was observed using the respective inhibitors. Although caspase-1 is activated following IFN treatment, blocking of this caspase did not lead to any reduction in the amount of apoptotic cells. Therefore it does not seem to play a major role in IFN-induced apoptosis. Overexpression of caspase-1 can induce apoptosis, however, its role in the apoptotic process under more physiological circumstances has been disputed. The fact that caspase-1 is activated by IFNa may thus rather re¯ect the involvement of this caspase in pro-in¯am-matory responses through its activation of cytokines such as IL-1b (Garcia-Calvo et al., 1999) .
The use of speci®c caspase inhibitors also gave an insight into the hierarchic activation of the caspase cascade following IFN-treatment. Our data indicate that caspase-8 is epistatic to caspases-2, -3 and -9, whereas caspase-3 is downstream in this series of events. Caspase-2 activation seems to occur between caspase-8 and -9, but from the present data it can not be excluded that caspase-8 may also activate caspase-9 in a caspase-2 independent manner. The fact that inhibition of caspase-9 and -3 does not aect caspase-8 activation strongly speaks against a scenario where activation of caspase-8 is a post-mitochondrial event, which has been shown to be the case in some types of chemotherapy induced apoptosis. Taken together, these data rather suggests that, in this system, caspase-8 induction is the triggering event in the caspase cascade induced by IFNa. A model with caspase-8 being the most upstream caspase in IFN-induced apoptosis may also explain why the relative caspase-8 activation is comparatively low, as this is usually the case for initiator caspases in comparison to caspases downstream in the cascade. A triggering function of caspase-8 is further strengthened by the fact that inhibition of this caspase causes the most prominent reduction in IFNa-induced apoptosis in comparison to the other speci®c inhibitors (Table 1) . This is an interesting notion since this caspase is regarded as an initiator caspase, whose activation has been associated with Figure 6 Eects in U266 (a ± d) and Rhek-1 (e) cells on IFNa-induced activation of caspases-2, -3, -8 and -9 after 48 h of culturing in the presence of (a) 5 mM DEVD-fmk (b) 1 mM VDVAD-fmk (c) 1 mM LEHD-fmk (d ± e) 10 mM IETD-fmk, inhibitors of caspases-3, -2, -9 and -8 respectively ligation of various cell surface`death receptors' such as the Fas and TNF-receptors. Although it has been shown that IFNa can cause an upregulation of both the Fas ligand and the Fas molecule itself, our data using an antagonistic Fas antibody do not support a direct role for the FAS-receptor in IFN-mediated apoptosis. It will be of interest to determine whether IFNa-induced apoptosis is associated with activation of any other death receptor such as TRAIL, which has been shown to be upregulated by IFNs (Kayagaki et al., 1999; Sedger et al., 1999) . It may also be that IFN signalling could directly activate caspase-8, independent of cytokine-induced death receptor activation, for example via the previously mentioned association between STAT1 and the TRADD molecule, normally involved in TNF-induced cytotoxicity . Re¯ected as a loss of C mit , we also found that mitochondrial function was disrupted in IFN-treated cells undergoing apoptosis. This indicates that the Figure 7 Eects of IFNa on mitochondrial membrane integrity as measured by TMRE incorporation in (a) U266 and (b) Daudi cells after 12, 24 and 48 h of culturing. In U266 cells a reduction in mitochondrial membrane potential is observed after 24 h of culturing and is further decreased after 48 h. In Daudi cells no reduction in mitochondrial membrane potential is observed post treatment with IFNa release of pro-apoptotic factors through the PT-pore may play an important role also in IFNa-induced apoptosis. The involvement of mitochondria in IFNinduced apoptosis was also further supported by the ®nding that cytochrome c is released into the cytosol of cells exposed to IFN. In accordance with this, we also found activation of caspase-9, an event that has been shown to be dependent on the formation of the cytochrome c containing apoptosome complex (Li et al., 1997) .
Our data on the eects of IFN on caspases and mitochondrial function, are in many ways reminiscent of the pattern of activation described for death receptor mediated apoptosis in so called type II cells. In this situation a relatively weak caspase-8 activation relies on a mitochondrial ampli®cation loop of the apoptotic signal for the apoptotic process to occur (Scadi et al., 1998) .
The response in the Daudi cell line, which is highly sensitive to several other IFN eects, was also investigated. As demonstrated in previous studies, this cell line responds to IFN-treatment with a prominent G0/G1 arrest, without induction of apoptosis. No clear activation of caspases was detected in this cell line. It was also found that the basal levels of caspase activation was much lower in Daudi cells compared to the cell lines sensitive to IFN-induced apoptosis, U266 and Rhek-1. Furthermore, no loss in mitochondrial C mit was observed following IFNa-treatment of Daudi cells. The reason for the resistance to IFN-induced apoptosis in Daudi cells remains to be de®ned. However, one explanation may be the previously reported mutation in the pro-apoptotic Bax protein in this cell line (Meijerink et al., 1998) . Another possible reason could be that this cell line expresses EBV encoded proteins that in some way might serve as protection, since many viruses have developed strategies to avoid the induction of apoptosis in their host cells (Silins and Sculley, 1995; Henderson et al., 1991) .
In conclusion, we have shown that IFNa-mediated apoptosis in malignant cells is largely dependent on the activation of dierent caspases, and is also associated with the disruption of mitochondrial integrity and release of cytochrome c. Moreover, our data suggest a chain of events with caspase-8 as the initiator of the caspase cascade. In our future studies we will focus on de®ning the upstream regulatory pathways that may activate the caspase cascade in this system. It will be of interest to examine whether IFNa-induced apoptosis is mainly a result of STAT regulated changes in transcription of speci®c genes, or whether other signalling pathways, such as the NF-kb, MAP-kinase and PI3-kinase pathways, known to be directly aected by IFN-receptor activation, may be of importance in this respect. An elucidation of the molecular events underlying IFN-induced apoptosis may aid in the future de®nition of prognostic subgroups of cancer patients that are more likely to respond to IFN therapy. It may also be helpful in 
Materials and methods
Cell lines, culture conditions and Interferon preparation
All included experiments were repeated at least three times. Data shown in ®gures and tables are from representative experiments. Three dierent cell lines were used in this study; Daudi cells (from a Burkitt's lymphoma) (Sangfelt et al., 1997) , SV40 transformed keratinocytes, Rhek-1 (Rhim, 1989) , and the multiple myeloma cell line U266 (Sangfelt et al., 1997) . All cells were cultured in RPMI 1640 (GIBCO, Berlin, Germany) supplemented with 10% heat-inactivated foetal calf serum (GIBCO, Berlin, Germany), 2 mM glutamine, 50 mg/ml of streptomycin, 50 mg/ml of penicillin and maintained in 5% CO 2 at 378C.
Recombinant human IFNa 2 b (Schering-Plough, Kenilworth, NJ, USA) was used for the in vivo experiments. The IFN preparation had a speci®c activity of 2.0610 8 units/mg and the purity was 499%. In preliminary experiments, the cellular events following IFNa treatment were found to take place in a dose-response dependent fashion, with apoptosis occurring using doses as low as 15 units/ml and a maximum eect at 5000 units/ml, wherefore this latter dose was chosen for the remaining experiments.
Quantification of IFNa-induced apoptosis
The experiments were performed by culturing exponentially growing cells in the presence or absence of 5000 units/ml of IFNa for up to 48 h. Two types of staining; Gentiana violet according to TuÈ rk and Annexin V, were used for evaluation of the percentage of apoptotic cells. DNA labelling and¯ow cytometric analysis generating DNA histograms were performed for investigation of both cell cycle eects and apoptosis.
Cells stained with TuÈ rk solution were counted in a light microscope and judged as apoptotic or non-apoptotic by nuclear morphology, with apoptotic cells displaying fragmented and/or condensed nuclei.
Redistribution of plasma membrane phosphatidyl serine (PS) is a marker of apoptosis and was assessed using Annexin V FLUOS (Boehringer Mannheim, Mannheim, Germany) according to the manufacturer's protocol. Brie¯y, 10 6 cells were collected, washed in PBS, pelleted and resuspended in Incubation buer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl 2 ) containing 1% Annexin V and 0.5 mg/ml Propidium Iodide (PI). The samples were kept in the dark and incubated for 15 min prior to addition of another 400 ml Incubation buer and analysis by a FACS calibur¯ow cytometer (Becton Dickinson, Stockholm, Sweden) using the Cell Quest software.
For analysis of DNA content, cells were ®xed in 4% formaldehyde in phosphate buer for 18 h, followed by 95% ethanol and ®nally treated with subtilisin Carlsberg solution (0.1% Sigma protease XXIV, 0.1 M Tris-HCl, 70 mM NaCl, pH 7.2) and stained with DAPI-sulforhodamine solution (8 mM DAPI, 50 mM sulforhodamine 101, 0.1 M Tris and 70 mM NaCl, pH 7.5) as previously described (Castro et al., 1993) . Samples were analysed using a PAS II¯ow cytometer (Partec, MuÈ nster, Germany) equipped with a 100 W mercury arc lamp, HBO100. DAPI¯uorescence was excited at 365 nm and measured above 435 nm. Flow cytometric data were analysed using the Multicycle AV program (Phoenix Flow Systems, San Diego, CA, USA). The amount of apoptotic cells as analysed with this method is represented by the sub G1 fraction of cells.
Caspase inhibitors and antibodies
To block the activity of caspases acting in dierent pathways or at dierent stages of apoptosis, several caspase inhibitors were used. The pan-caspase inhibitor z-VAD-FMK (Z-ValAla-Asp(OMe)-¯uoromethylketone) and inhibitors of caspase-3 and -7, z-DEVD-FMK (Z-Asp ( Antagonistic inhibition of the Fas(CD95)-receptor was performed using the Fas mAb B-D29 from Diaclone (Besancon, France).
Antibodies against pro-caspase-8 (mouse IgG, gift from Dr PH Krammer, German Cancer Research Center, Heidelberg, Germany) and the p17 subunit of caspase-3 (rabbit IgG, gift from Dr Donald W Nicholson, Merck Frosst Centre for Therapeutic Research, Quebec, Canada) were used in Western blot experiments. Peroxidase conjugated goat anti-rabbit IgG and goat anti-mouse IgG from Pierce (Rockford, USA) at 1 : 10 000 were used as secondary antibodies.
In vitro caspase assay Caspase activity was measured by cleavage of the following substrates: Ac-YVAD-AMC (caspase-1), Ac-VDVAD-AMC (caspase-2), Ac-DEVD-AMC (caspase-3 like), Ac-IETD-AMC (caspase-8); and Ac-LEHD-AMC (caspase-9) in ā uorometric assay as described previously (Garcia-Calvo et al., 1999) . Brie¯y, aliquots containing 1.0610 6 cells were washed once with ice-cold PBS, pelleted, resuspended in 25 ml PBS and then transferred to a 96-well plate. Fifty ml of freshly prepared substrate buer (100 mM HEPES, 10% sucrose, 0.1% CHAPS (3-(3-Cholamidopropyl)dimethylammonio-1-propane-sulfonate), 5 mM DTT (dithiothreitol), 10 -6 % NP-40, pH 7.25 for caspase-1, -3 and ± 8) and 100 mM MES (2-[N-Morpholino] ethanesulfonic acid), 10% PEG (Polyethylene Glycol), 0.1% CHAPS, 10 mM DTT, 10 -6 % NP-40, pH 6.5 for caspase-2 and -9) containing the respective substrates were added per well. All substrates were dissolved in DMSO and the ®nal concentration in mixture with cells was 33.3 mM for Ac-YVAD-AMC, Ac-VDVAD-AMC and Ac-DEVD-AMC, and 13.6 mM for Ac-IETD-AMC and Ac-LEHD-AMC, respectively. The enzymatic reaction was carried out at 378C. Cleavage of the¯uorogenic peptide substrate was monitored by AMC liberation in a Fluoroscan II plate reader (Labsystems, Stockholm, Sweden) using 355 nm excitation and 460 nm emission wavelengths. Fluorescence units were converted to pmol of AMC per min per 10 6 cells using a standard curve generated with free AMC. Data from duplicate samples were then analysed by linear regression. Experiments were performed in duplicates and the activity was expressed as change in¯uorescence units. All substrates were from Peptide Institute Inc. (Osaka, Japan).
Western blot analysis
Western blot analysis was performed essentially as described (Reynisdottir et al., 1995) . Brie¯y, 5610 6 cells were prepared by lysis through sonication in LSLD buer (50 mM HEPES at pH 7.4, 50 mM NaCl, 10% Glycerol, 0.1 % Tween 20, 0.3 mM Na-orthovanadate, 50 mM NaF, 80 mM b-glycerophosphate, 20 mM Na-pyrophosphate, 1 mM DTT and 1 mM phenyl-methyl-sulphonyl¯uoride (PMSF), 10 mg/ml of leupeptin, 10 mg/ml of antipain, 100 mg/ml of benzamidine hydrochloride, 5 mg/ml of aprotinin and 100 mg/ml of soybean trypsin inhibitor). Protein concentration was quantitated spectrophotometrically with a protein assay kit, according to the manufacturer's instructions (Bio-Rad, Hercules, CA, USA). Forty mg of protein was loaded in each well and the proteins were resolved on a 12% SDS ± PAGE and electroblotted to PVDF-membranes (Boehringer Mannheim, Germany) by semi-dry transfer. For protein detection, the ®lters were hybridized with the appropriate primary antibody and thereafter with a secondary antibody for 1 h respectively. Protein bands were visualized by ECL according to the manufacturer's protocol (Amersham, Aylesbury, UK)
TMRE staining
Reduction in mitochondrial membrane potential, C mit , is one of the hallmarks often possessed by apoptotic cells. In order to detect changes in the C mit of IFNa treated cells compared to cells cultured in the absence of IFNa, cells were stained with Tetramethylrhodamine ethyl ester perchlorate (TMRE) (Molecular Probes Inc., Eugene, OR, USA). Brie¯y, 10 6 cells were cultured in the presence and absence of IFNa for dierent timepoints, subsequently TMRE was added to a ®nal concentration of 25 nM, a concentration that remained throughout the experiment, and incubated for 30 min. Cells were pelleted and washed in PBS and TMRE once, thereafter 100 ml of incubation buer (10 mM HEPES/NaOH pH 7.4, 140 mM NaCl, 5 mM CaCl 2 , 25 nM TMRE) containing 1% Annexin V FLUOS was added for 10 min, and samples were kept in the dark. Prior to¯ow cytometric analysis, another 400 ml of incubation buer was added.
Cytochrome c release Cells were incubated for 30 min in normal growth medium containing 10 nM Mitotracker Red CMXRos (Molecular Probes Inc., Eugene, OR, USA). Thereafter, cells were cytospinned on glass slides, ®xed in 3% PFA for 20 min and permeabilized in 0.2% Triton X-100 in PBS for 10 min. Staining with an anti-cytochrome c antibody (Pharmingen, USA) was performed for 1 h at RT, followed by incubation with a secondary rabbit anti-mouse FITC-conjugated antibody (DAKO). The images were recorded on DAS Leitz DM RB microscope with a Hamamatsu C4880 dual mode cooled CCD camera and further processed using a Photoshop software (Adobe Systems Inc.).
